117 related articles for article (PubMed ID: 23486431)
1. BRAF and MC1R in melanoma: different in head and neck tumors?
Fink EC; Fisher DE
J Invest Dermatol; 2013 Apr; 133(4):878-80. PubMed ID: 23486431
[TBL] [Abstract][Full Text] [Related]
2. NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.
Hacker E; Nagore E; Cerroni L; Woods SL; Hayward NK; Chapman B; Montgomery GW; Soyer HP; Whiteman DC
J Invest Dermatol; 2013 Apr; 133(4):1027-33. PubMed ID: 23096702
[TBL] [Abstract][Full Text] [Related]
3. BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
García-Casado Z; Traves V; Bañuls J; Niveiro M; Gimeno-Carpio E; Jimenez-Sanchez AI; Moragón M; Onrubia JA; Oliver V; Kumar R; Nagore E
Br J Dermatol; 2015 Apr; 172(4):1128-31. PubMed ID: 25385688
[No Abstract] [Full Text] [Related]
4. Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.
Thomas NE; Edmiston SN; Kanetsky PA; Busam KJ; Kricker A; Armstrong BK; Cust AE; Anton-Culver H; Gruber SB; Luo L; Orlow I; Reiner AS; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Parrish EA; Hao H; Gibbs DC; Frank JS; Ollila DW; Begg CB; Berwick M; Conway K;
J Invest Dermatol; 2017 Dec; 137(12):2588-2598. PubMed ID: 28842324
[TBL] [Abstract][Full Text] [Related]
5. Germline MC1R variants and frequency of somatic BRAF, NRAS, and TERT mutations in melanoma: Literature review and meta-analysis.
Zanna I; Caini S; Raimondi S; Saieva C; Masala G; Massi D; Cocorocchio E; Queirolo P; Stanganelli I; Gandini S
Mol Carcinog; 2021 Mar; 60(3):167-171. PubMed ID: 33444485
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis.
Pellegrini C; Di Nardo L; Cipolloni G; Martorelli C; De Padova M; Antonini A; Maturo MG; Del Regno L; Strafella S; Micantonio T; Leocata P; Peris K; Fargnoli MC
J Mol Diagn; 2018 Jan; 20(1):110-122. PubMed ID: 29061376
[TBL] [Abstract][Full Text] [Related]
7. Germline MC1R variants and BRAF mutant melanoma.
Hacker E; Hayward NK
J Invest Dermatol; 2008 Oct; 128(10):2354-6. PubMed ID: 18787543
[TBL] [Abstract][Full Text] [Related]
8. MC1R variants increase risk of melanomas harboring BRAF mutations.
Fargnoli MC; Pike K; Pfeiffer RM; Tsang S; Rozenblum E; Munroe DJ; Golubeva Y; Calista D; Seidenari S; Massi D; Carli P; Bauer J; Elder DE; Bastian BC; Peris K; Landi MT
J Invest Dermatol; 2008 Oct; 128(10):2485-90. PubMed ID: 18368129
[TBL] [Abstract][Full Text] [Related]
9. Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors.
Scherer D; Rachakonda PS; Angelini S; Mehnert F; Sucker A; Egberts F; Hauschild A; Hemminki K; Schadendorf D; Kumar R
J Invest Dermatol; 2010 Dec; 130(12):2844-8. PubMed ID: 20720566
[No Abstract] [Full Text] [Related]
10. Melanoma molecular subtypes: unifying and paradoxical results.
Thomas NE; Kanetsky PA; Begg CB; Conway K; Berwick M
J Invest Dermatol; 2010 Jan; 130(1):12-4. PubMed ID: 20010862
[TBL] [Abstract][Full Text] [Related]
11. MC1R germline variants confer risk for BRAF-mutant melanoma.
Landi MT; Bauer J; Pfeiffer RM; Elder DE; Hulley B; Minghetti P; Calista D; Kanetsky PA; Pinkel D; Bastian BC
Science; 2006 Jul; 313(5786):521-2. PubMed ID: 16809487
[TBL] [Abstract][Full Text] [Related]
12. The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population.
Hacker E; Hayward NK; Dumenil T; James MR; Whiteman DC
J Invest Dermatol; 2010 Jan; 130(1):241-8. PubMed ID: 19571821
[TBL] [Abstract][Full Text] [Related]
13. Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.
Thomas NE; Kanetsky PA; Edmiston SN; Alexander A; Begg CB; Groben PA; Hao H; Busam K; Ollila DW; Berwick M; Conway K
J Invest Dermatol; 2010 May; 130(5):1463-5. PubMed ID: 20043015
[No Abstract] [Full Text] [Related]
14. Functional interplay between secreted ligands and receptors in melanoma.
Herraiz C; Jiménez-Cervantes C; Sánchez-Laorden B; García-Borrón JC
Semin Cell Dev Biol; 2018 Jun; 78():73-84. PubMed ID: 28676423
[TBL] [Abstract][Full Text] [Related]
15. BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study.
Frank GA; Aleksakhina SN; Zavalishina LE; Kekeyeva TV; Venina AR; Ivantsov AO; Mitiushkina NV; Moiseyenko AV; Pfeifer W; Strelkova TN; Imyanitov EN
Melanoma Res; 2016 Oct; 26(5):442-7. PubMed ID: 27433783
[No Abstract] [Full Text] [Related]
16. Lack of somatic alterations of MC1R in primary melanoma.
Kim RD; Curtin JA; Bastian BC
Pigment Cell Melanoma Res; 2008 Oct; 21(5):579-82. PubMed ID: 18761657
[TBL] [Abstract][Full Text] [Related]
17. Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study.
Zebary A; Omholt K; van Doorn R; Ghiorzo P; Harbst K; Hertzman Johansson C; Höiom V; Jönsson G; Pjanova D; Puig S; Scarra GB; Harland M; Olsson H; Egyhazi Brage S; Palmer J; Kanter-Lewensohn L; Vassilaki I; Hayward NK; Newton-Bishop J; Gruis NA; Hansson J;
J Invest Dermatol; 2014 Jan; 134(1):287-290. PubMed ID: 23771122
[No Abstract] [Full Text] [Related]
18. Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.
Fargnoli MC; Sera F; Suppa M; Piccolo D; Landi MT; Chiarugi A; Pellegrini C; Seidenari S; Peris K
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1768-75. PubMed ID: 24588892
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
20. Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.
Herraiz C; Journé F; Ghanem G; Jiménez-Cervantes C; García-Borrón JC
Int J Biochem Cell Biol; 2012 Dec; 44(12):2244-52. PubMed ID: 23000456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
